Related Experiment Video
Updated: Jun 5, 2025

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 3, 2010
Rhino-Orbito-Cerebral Mucormycosis in an Immunocompromised Patient
Heung Eog Cha1, Jin Uk Jeong1, Joo Hyun Jung1
1Department of Otolaryngology-Head & Neck Surgery, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea.
Abstract:
Rhino-orbito-cerebral mucormycosis (ROCM) is an invasive fungal infection that usually occurs in immunocompromised patients. It is aggressive and has a high risk of mortality. With unclear guidelines, ROCM is treated in various ways. We present a patient who underwent kidney transplant and who treated for ROCM without major complications.
Insights
Rhino-orbito-cerebral mucormycosis (ROCM) is a severe fungal infection affecting immunocompromised individuals. This case study details successful ROCM treatment in a kidney transplant patient, highlighting effective management strategies.
Area of Science:
- Mycology
- Infectious Diseases
- Transplant Surgery
Background:
- Rhino-orbito-cerebral mucormycosis (ROCM) is a life-threatening invasive fungal infection.
- ROCM predominantly affects immunocompromised patients, including transplant recipients.
- Current treatment guidelines for ROCM are not well-established, leading to varied clinical approaches.
Observation:
- A kidney transplant recipient presented with ROCM.
- The patient's ROCM was managed without significant complications.
- This case highlights a specific treatment course for ROCM in a post-transplant setting.
Findings:
- Successful treatment of ROCM was achieved in an immunocompromised kidney transplant patient.
- The presented management strategy for ROCM proved effective and safe.
- The case demonstrates a viable approach to ROCM in a complex patient population.
Implications:
- This case provides valuable insights into ROCM management in kidney transplant recipients.
- Findings may inform the development of clearer clinical guidelines for ROCM treatment.
- Successful outcomes suggest that aggressive fungal infections can be managed effectively in transplant patients.
Related Concept Videos
Fungal Group Zygomycota
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

